(Q47660684)

English

Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

0 references

0 references

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

Alan H B Wu

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

Andrew Smith

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

Stacey Wieczorek

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

Jeffrey F Mather

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

Bret Duncan

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

C Michael White

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

Carol McGill

7

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

Deb Katten

8

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

Gary Heller

9

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

language of work or name

0 references

publication date

1 September 2003

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

American Journal of Cardiology

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

92

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

628-631

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900741-0

7 January 2021

Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900741-0

7 January 2021

Generation and application of data on biological variation in clinical chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900741-0

7 January 2021

Deconvolution analysis of cardiac natriuretic peptides during acute volume overload

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900741-0

7 January 2021

Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900741-0

7 January 2021

A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900741-0

7 January 2021

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900741-0

7 January 2021

The role of tumor necrosis factor alpha blockade in the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900741-0

7 January 2021

Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900741-0

7 January 2021

Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2803%2900741-0

7 January 2021

Identifiers

10.1016/S0002-9149(03)00741-0

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/12943894

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47660684&oldid=2067485571"